On September 23, 2022, Timothy E. Morris informed Humanigen, Inc. (the Company") of his resignation from his position as Chief Operating Officer of the Company, effective October 23, 2022. Dr. Cameron Durrant, the Company's Chairman of the Board and Chief Executive Officer, will assume additional duties as principal financial and accounting officer of the Company until a successor to Mr. Morris is identified.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0003 USD | +50.00% | +50.00% | -75.00% |
Apr. 12 | Combined Liquidation Plan and Disclosure Statement Filed by Humanigen, Inc. | CI |
Mar. 08 | Final DIP Financing Approved for Humanigen, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-75.00% | 35.72K | |
-3.79% | 88.14B | |
+1.45% | 40.51B | |
-15.94% | 31.67B | |
+52.66% | 24.62B | |
-14.50% | 15.65B | |
-14.38% | 12.07B | |
-9.12% | 11.97B | |
-42.56% | 11.61B | |
+4.87% | 8.81B |
- Stock Market
- Equities
- HGENQ Stock
- News Humanigen, Inc.
- Humanigen, Inc. Announces Executive Changes